Jefferies Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-13,000
Closed -$863K – 1855
2025
Q4
$863K Sell
13,000
-150,000
-92% -$9.7M ﹤0.01% 1144
2025
Q3
$11M Buy
163,000
+150,000
+1,154% +$11.9M 0.05% 221
2025
Q2
$1.13M Buy
+13,000
New +$1.02M 0.01% 698

Other funds holding DXCM

Jefferies Financial Group's DXCM Position: Q3 2026 in Review

Jefferies Financial Group reduced its DexCom (DXCM) stake by 3.9% in Q3 2026, selling an estimated $202K and leaving 59,009 shares worth $5.09M. The position accounts for 0.04% of the portfolio, ranked #319.

Jefferies Financial Group first reported a position in DXCM in Q4 2022 and has held it in 16 quarters since. The position peaked at $7.97M in Q4 2022. 1,043 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Jefferies Financial Group held 59,009 shares of DexCom worth $5.09M as of Q3 2026.
  • Jefferies Financial Group sold 2,425 DexCom shares in Q3 2026, an estimated $202K.
  • DexCom made up 0.04% of Jefferies Financial Group's portfolio in Q3 2026, its #319 holding.
  • Jefferies Financial Group first reported a position in DexCom in Q4 2022 and has held it in 16 quarters since.
  • Jefferies Financial Group's DexCom position peaked at $7.97M in Q4 2022.
  • 1,043 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.